23-10-30 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-08-03 GSK Nigeria calls an end to its business, to return cash RE
23-08-03 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
23-08-03 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
23-04-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
23-01-27 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
23-01-27 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-10-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
22-07-29 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
22-04-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
22-01-31 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
21-10-25 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
21-07-29 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 2011-07-31
General Counsel - 2017-01-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.81M
+1.57%+10.31%+63.52%+143.15% 1,257B
-0.44%+1.60%+43.25%+80.09% 651B
+0.18%+0.73%+32.47%+101.62% 510B
-0.26%-0.63%+52.79%+67.12% 388B
-1.46%+5.51%+72.55%+44.25% 366B
+0.67%+2.67%+32.88%+58.65% 303B
+0.03%+8.11%+12.12%+34.98% 288B
-0.48%+4.68%+55.97%+74.59% 252B
-0.02%+7.34%+42.19%+109.69% 211B
Average +0.09%+4.59%+45.31%+79.35% 469.63B
Weighted average by Cap. +0.31%+5.30%+49.23%+93.68%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock